Roggeri, D.P. et al. 2016. [Kovaltry® for the replacement therapy in patients with Hemophilia A]. Farmeconomia. Health economics and therapeutic pathways. 17, 2 (Jun. 2016), 97–100. DOI:https://doi.org/10.7175/fe.v17i2.1250.